<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01505296</url>
  </required_header>
  <id_info>
    <org_study_id>BWI-IIS-0143</org_study_id>
    <nct_id>NCT01505296</nct_id>
  </id_info>
  <brief_title>Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation</brief_title>
  <acronym>CABAL</acronym>
  <official_title>Randomized Comparison of Catheter Ablation Versus Anti-arrhythmic Drug Therapy in Patients With Recently Diagnosed Paroxysmal Atrial Fibrillation as Assessed by a Continuous Implantable Monitor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Valley Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biosense Webster, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Valley Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to compare the progression of Atrial Fib (AF) burden by continuous
      monitoring in patients with recently diagnosed paroxysmal AF treated by catheter ablation
      (PVI) versus anti-arrhythmic drug (AAD) therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized, multicenter clinical trial comparing medical therapy (Group I) with ablation
      therapy(Group II). Randomization will be determined by opening a sealed envelope. All
      patients will be implanted with an implantable loop recorder and followed every three months.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Never initiated
  </why_stopped>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of AF burden</measure>
    <time_frame>4 months</time_frame>
    <description>The percentage of AF burden defined through continuous monitoring using an implnatage loop recorder (ILR)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-death death</measure>
    <time_frame>4 months</time_frame>
    <description>All-cause death, thromboembolic events, hospitalizations, procedural complications, drug adverse effects, and number of crossovers</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Antiarrhythmic drug</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Class I or III antiarrhythmic drug</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Catheter ablation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pulmonary vein isolation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antiarrhythmic drug</intervention_name>
    <description>propafenone, flecainide, sotalol, dofetilide</description>
    <arm_group_label>Antiarrhythmic drug</arm_group_label>
    <other_name>Rhythmol, Tambocor, Betapace, Tikosyn</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Catheter ablation</intervention_name>
    <description>Complete PVI</description>
    <arm_group_label>Catheter ablation</arm_group_label>
    <other_name>Thermocool</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with recently diagnosed paroxysmal AF who are eligible to receive specific
             rhythm control therapy

        Exclusion Criteria:

          -  Previous treatment with Class IC or class III AAD

          -  Previous AF ablation procedure

          -  Congestive heart failure (NYHA III-IV functional class)

          -  Left Ventricle ejection fraction less than 35%

          -  Left atrial diameter &gt; 55mm

          -  Unwillingness to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan Steinberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Valley Health System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Evegny Pokushalou, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>State Resarch Institute of Circulation Pathology, Novosibirsk, Siberia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Valley Health System</name>
      <address>
        <city>Ridgewood</city>
        <state>New Jersey</state>
        <zip>07450</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Research Institute of Circulation Pathology</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://arrythmia.org</url>
    <description>Click here for more information</description>
  </link>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2011</study_first_submitted>
  <study_first_submitted_qc>January 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2012</study_first_posted>
  <last_update_submitted>December 13, 2014</last_update_submitted>
  <last_update_submitted_qc>December 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Valley Health System</investigator_affiliation>
    <investigator_full_name>Jonathan Steinberg,MD</investigator_full_name>
    <investigator_title>Director Arrhythmia Services, Valley Health System</investigator_title>
  </responsible_party>
  <keyword>Catheter ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Arrhythmia Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

